Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11958845
Heterocyclic compound
granted -
US 11957684
Treatment of heavy menstrual bleeding associated with uterine fibroids
granted -
US 11958850
Heteroaryl compounds for kinase inhibition
granted -
US 11957867
Syringe stabilizer
granted -
US 11952344
Heterocyclic compound and use thereof
granted -
US 11939327
Heterocyclic compounds
granted -
US 11938174
Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders
granted -
US 11905285
Inhibitors of plasma kallikrein and uses thereof
granted -
US 11897879
Heterocyclic compound
granted -
US 11892450
Evaluation, assays and treatment of pKal-mediated disorders
granted -
US 11884731
Vedolizumab for the treatment of fistulizing Crohn's disease
granted -
US 11884945
Methods for purification of arylsulfatase A
granted -
US 11857575
Mesenchymal stem cell-derived exosomes and their uses
granted -
US 11851481
Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
granted -
US 11851449
Heterocyclic amide compounds having an RORvt inhibitory action
granted -
US 11834409
Heterocyclic NMDA antagonists
granted -
US 11827601
Heterocyclic NMDA antagonists
granted -
US 11815516
Protein biomarkers for diseases associated with the contact activation system
granted -
US 11793812
Methods of treating endometriosis
granted -
US 11793855
TFPI inhibitors and methods of use
granted -
US 11795216
Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics
granted -
US 11787796
Plasma Kallikrein inhibitors and uses thereof
granted -
US 11786608
Isoquinolinyl triazolone complexes
granted -
US 11779635
Subcutaneous administration of ADAMTS13
granted